Sonja Baumli

The structure of P‐TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation

Sonja Baumli, Graziano Lolli, E.D. Lowe et al. · The EMBO Journal · 2008 · 345 citations · Full text

Functional Architecture of RNA Polymerase I

Claus‐D. Kuhn, S. Geiger, Sonja Baumli et al. · Cell · 2007 · 211 citations · Full text

Engineering, Functional Architecture, Natural Sciences +8

Structure and VP16 binding of the Mediator Med25 activator interaction domain

Erika Vojnic, André Mourão, Martin Seizl et al. · Nature Structural & Molecular Biology · 2011 · 123 citations · Full text

Signal Transduction, Medicine, Vp16 Binding +6

Substituted 4-(Thiazol-5-yl)-2-(phenylamino)pyrimidines Are Highly Active CDK9 Inhibitors: Synthesis, X-ray Crystal Structures, Structure–Activity Relationship, and Anticancer Activities

Hao Shao, Shenhua Shi, Shi‐Liang Huang et al. · Journal of Medicinal Chemistry · 2013 · 121 citations · Full text

Structure–activity Relationship, Drug Target, Heterocycle Chemistry +17

Halogen Bonds Form the Basis for Selective P-TEFb Inhibition by DRB

Sonja Baumli, Jane Endicott, L.N. Johnson · Chemistry & Biology · 2010 · 120 citations

Molecular Pharmacology, Medicinal Chemistry, Selective P-tefb Inhibition +12